Metabolic Abnormalities and Intestinal Microecology in Patients With Chronic Disorders of Consciousness
1 other identifier
observational
200
1 country
1
Brief Summary
Following severe traumatic brain injury, patients may remain unconscious for many years. It is the intestinal microbiome and metabolomics analysis comparing differentially intestinal microflora and metabolites between patients with chronic disorder of consciousness and controls so far. The investigators have mature data analysis technology. The obtained results provide new insight into understanding the molecular mechanisms underlying the chronic disorder of consciousness
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2018
CompletedFirst Submitted
Initial submission to the registry
July 29, 2020
CompletedFirst Posted
Study publicly available on registry
August 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedMay 7, 2024
July 1, 2020
4.5 years
July 29, 2020
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
metabolic profiling and Intestinal microbial spectrum
A comprehensive metabolic profile from plasma was obtained with targeted metabolomics analysis and untargeted and targeted lipidomics analysis; intestinal microbial spectrum was obetained from fecal by16S rRNA gene sequencing among HCs, EMCS, MCS and VS groups.
1 month
Secondary Outcomes (3)
Coma Recovery Scale-Revised(CRS-R)
30 minutes before samples collection
Glasgow Outcome Scale (GOS)
6 months
Indicators of brain connectivity by EEG
On the same day as collecting the samples
Study Arms (4)
Emerged from Minimally Conscious State (EMCS)
Emerged from Minimally Conscious State (EMCS): recovery of functional object uses or communication from chronic
Minimally conscious state (MCS)
Minimally conscious state (MCS): have reproducible signs of awareness and exhibit fluctuations in consciousness
Vegetative state (VS)
Vegetative state (VS): can open their eyes and preserve sleep-wake cycles, but unaware of themselves and their surroundings
Healthy controls (HCs)
Healthy controls (HCs)
Interventions
No intervention
Eligibility Criteria
Patients with chronic disorder of consciousness were recruited at the rehabilitation units of Hangzhou Hospital of Zhejiang Armed Police Corps, China and Hangzhou Mingzhou Brain Rehabilitation Hospital.
You may qualify if:
- Patients ages 18 to 80 years old;
- Patients had a history of severe Traumatic brain injury (TBI);
- Patients had awakened from a coma (indicating preserved sleep-wake cycles), including vegetative state and minimally consciousness state;
- Patients stay unconscious for more than 1 month.
You may not qualify if:
- Patients with disorders of consciousness caused by other inducements;
- Other neurological or psychiatric conditions prior to the current brain injury;
- Persistent seizure-like activity, inhibition or seizure inhibition;
- The patients had taken a sedative barbiturate neuroleptics or antidepressants within one month;
- The clinical state is unstable, and there are signs of spontaneous recovery or deterioration within 1 week;
- The patients have taken gastrointestinal motility drugs or other drugs affecting gastrointestinal motility in the past month;
- Had taken antibiotics and probiotics in the past month;
- Patients with intestinal diseases such as colon cancer, ulcerative colitis or crohn's disease;
- Patients with acute infectious diseases or liver dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SCIEX QTRAP 5500 liquid chromatograph / triple quadrupole mass spectrometer.
Hangzhou, Zhejiang, 310002, China
Biospecimen
Plasma for metabolites and lipids;Fecal samples for microbiome and metabolites.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2020
First Posted
August 28, 2020
Study Start
March 13, 2018
Primary Completion
September 1, 2022
Study Completion
April 1, 2023
Last Updated
May 7, 2024
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share